tiprankstipranks
Euromedis Groupe SA (DE:61R)
FRANKFURT:61R

Euromedis Groupe SA (61R) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Euromedis Groupe SA has a market cap or net worth of €13.11M. The enterprise value is €3.43M.
Market Cap€13.11M
Enterprise Value€3.43M

Share Statistics

Euromedis Groupe SA has 2,886,754 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,886,754
Owned by Insiders
Owned by Institutions

Financial Efficiency

Euromedis Groupe SA’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -0.30%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-0.30%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee1.05M
Profits Per Employee-3.38K
Employee Count39
Asset Turnover1.03
Inventory Turnover2.64

Valuation Ratios

The current PE Ratio of Euromedis Groupe SA is ―. Euromedis Groupe SA’s PEG ratio is 0.87.
PE Ratio
PS Ratio0.28
PB Ratio0.68
Price to Fair Value0.68
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.87

Income Statement

In the last 12 months, Euromedis Groupe SA had revenue of 40.80M and earned -131.77K in profits. Earnings per share was -0.05.
Revenue40.80M
Gross Profit12.30M
Operating Income312.94K
Pretax Income550.74K
Net Income-131.77K
EBITDA874.98K
Earnings Per Share (EPS)-0.05

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Euromedis Groupe SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.03
52-Week Price Change19.16%
50-Day Moving Average4.89
200-Day Moving Average4.38
Relative Strength Index (RSI)57.56
Average Volume (3m)0.00

Important Dates

Euromedis Groupe SA upcoming earnings date is Apr 22, 2022, After Close (Confirmed).
Last Earnings DateSep 30, 2021
Next Earnings DateApr 22, 2022
Ex-Dividend Date

Financial Position

Euromedis Groupe SA as a current ratio of 2.47, with Debt / Equity ratio of 37.12%
Current Ratio2.47
Quick Ratio1.78
Debt to Market Cap0.54
Net Debt to EBITDA-12.07
Interest Coverage Ratio0.89

Taxes

In the past 12 months, Euromedis Groupe SA has paid 682.51K in taxes.
Income Tax682.51K
Effective Tax Rate1.24

Enterprise Valuation

Euromedis Groupe SA EV to EBITDA ratio is 0.80, with an EV/FCF ratio of 0.00.
EV to Sales0.02
EV to EBITDA0.80
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Euromedis Groupe SA has €16.67M in cash and marketable securities with €6.11M in debt, giving a net cash position of €10.57M billion.
Cash & Marketable Securities€16.67M
Total Debt€6.11M
Net Cash€10.57M
Net Cash Per Share€3.66
Tangible Book Value Per Share€5.62

Margins

Gross margin is 30.15%, with operating margin of 0.77%, and net profit margin of -0.32%.
Gross Margin30.15%
Operating Margin0.77%
Pretax Margin1.35%
Net Profit Margin-0.32%
EBITDA Margin2.14%
EBIT Margin0.77%

Analyst Forecast

The average price target for Euromedis Groupe SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast12.79%
EPS Growth Forecast97.86%

Scores

Smart ScoreN/A
AI Score